Innoblative is excited to partner with Maz Medical, a medical technologies provider in Greece offering innovative, reliable products and services, and to bring our SIRA® Device to their organization to further our mission.
#MazMedical#BreastAblation#Innoblative#SIRA
On this Memorial Day, we stand with members of the U.S. Armed Forces in remembrance of the fallen soldiers who served our country.
Their courage and dedication will always be remembered. Thank you for your sacrifice.
#MemorialDay#Remember#Honor#Innoblative#SIRA
Innoblative is thrilled to partner with @Grupocryo, a medical company committed to offering solutions for the diagnosis and treatment of localized cancer, and to bring our SIRA® Device to their organization to further our mission.
#GrupoCryo#Ablation#Cancer#Innoblative#SIRA
@ASBrS26 begins tomorrow in Seattle!
Join us Friday morning for our groundbreaking scientific symposium on Emerging Long-Term Data on BCS + Intraoperative RFA. Final chance to register for your spot! https://t.co/6sQgbKkf1y
#ASBrS2026#BreastSurgery#Innoblative#SIRA
The UTMB Pilot Trial exploring the use of radiofrequency ablation (heat) during lumpectomy is now listed on https://t.co/A4W2WUYBSW, helping connect more patients with potential treatment options.
Learn more by visiting: https://t.co/EW4iJDWtJv
#BreastCancer#ClinicalTrials
The @ASBrS Annual Meeting in Seattle, WA begins next week!
Reminder to register for our innovative symposium: “De-Escalation of Radiation in Low-Risk Breast Cancer: Emerging Long-Term Data on BCS + Intraoperative RFA and Feasibility of RT Reduction” and visit us at booth #424.
Our not to be missed symposium “De-Escalation of Radiation in Low-Risk Breast Cancer: Emerging Long-Term Data on BCS + Intraoperative RFA and Feasibility of RT Reduction” is in less than 2 weeks!
Space is limited so register for your today: https://t.co/6sQgbKkf1y
We are 2 weeks away from #ASBrS26 in Seattle!
Be sure to check out our symposium: “De-Escalation of Radiation in Low-Risk Breast Cancer: Emerging Long-Term Data on BCS + Intraoperative RFA and Feasibility of RT Reduction.” Register now for your spot!
And visit us at booth #424.
Our not to be missed symposium “De-Escalation of Radiation in Low-Risk Breast Cancer: Emerging Long-Term Data on BCS + Intraoperative RFA and Feasibility of RT Reduction” is in less than 3 weeks!
Space is limited so register for your today: https://t.co/6sQgbKkf1y
We are 3 weeks away from #ASBrS2026 in Seattle!
Don’t miss our symposium: “De-Escalation of Radiation in Low-Risk Breast Cancer: Emerging Long-Term Data on BCS + Intraoperative RFA and Feasibility of RT Reduction” and visit us at booth #424 to learn more about our SIRA® Device.
We are excited to exhibit at @ASBrS 2026 in Seattle later this month!
Reminder to join our symposium: “De-Escalation of Radiation in Low-Risk Breast Cancer: Emerging Long-Term Data on BCS + Intraoperative RFA and Feasibility of RT Reduction” and visit us at booth #424.
We are excited to exhibit at #ASBrS2026 in Seattle next month!
We invite you to join our special symposium on Emerging Long-Term Data on BCS + Intraoperative RFA. Register for your spot now!
Also visit us at booth #424 to learn more about our SIRA® RFA Electrosurgical Device.
The Innoblative team is excited to exhibit at @EORTC's #EBCC15 from March 25-27, 2026, in Barcelona.
Visit us at booth #12 to chat with our CEO, Richard Stark, and to learn more about how Innoblative is innovating healthcare. We look forward to connecting!
#Innoblative#SIRA
Press Release: AMA Approves Category III CPT® Code for Innoblative’s SIRA® RFA Electrosurgical Device, an Adjunct for Patients Undergoing Breast Conservation Surgery.
https://t.co/DUVhvr7uJS
#BreastCancerResearch#RFA#MedDevice#Innoblative#SIRA
Happy Presidents Day from Innoblative!
This Presidents Day, we reflect on the leadership and service that helps move our nation forward. We strive to build on that spirit to advance medical technology innovation at Innoblative.
#PresidentsDay2026#Innoblative#SIRA
Innoblative’s CEO, Richard Stark, will be at LSI USA ‘26 this March in Dana Point, CA.
Meet with Rick to learn more about our SIRA® RFA Electrosurgical Device by sending us a DM or calling 833-920-4660.
#LSIUSA26#LifeSciences#MedicalTechnology#Innoblative#SIRA
On #MartinLutherKingJrDay, we take a moment to reflect on his legacy.
Inspired by Dr. King’s belief in progress and purpose, we remain committed to advancing innovation that improves care, expands access, and helps create healthier communities for all.
#Innoblative#SIRA
Happy New Year from the Innoblative team!
As we look back on this past year and look forward to the next, we are thankful for our remarkable team and partners for your unwavering trust and support, and we can’t wait for the exciting things to come!
#NewYears#Innoblative
Happy Holidays from Innoblative!
May this season bring you and your loved ones joy, comfort, and meaningful celebrations. Whether near or far, we deeply appreciate your continued commitment to our mission.
#HolidaySeason#Celebration#Innoblative